Hematology & Oncology Doctors in Sandy Springs, GA Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Dr. Robert L. Stahl, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 525 Riverside Pkwy Nw, Sandy Springs, GA 30328 Phone: 404-932-6191

Dr. Janice A Galleshaw, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1100 Johnson Ferry Rd Ne, Suite 600, Sandy Springs, GA 30342 Phone: 404-256-4777    Fax: 404-256-5515

Dr. Mansoor N Saleh, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1100 Johnson Ferry Rd Ne, Suite 600, Sandy Springs, GA 30342 Phone: 404-256-4777    Fax: 404-256-5515

News Archive

Regular practice of Transcendental Meditation benefits active-duty service members

Regular practice of Transcendental Meditation enables some active duty service members battling post-traumatic stress disorder to reduce or even eliminate their psychotropic medication and get better control of their often-debilitating symptoms, researchers report in the journal Military Medicine.

Sterile Insect Technique can play a vital role in malaria elimination

The Sterile Insect Technique (SIT), the release of sexually sterile male insects to wipe out a pest population, is one suggested solution to the problem of malaria in Africa. A new supplement, published in BioMed Central's open access Malaria Journal, reviews the history of the technique, and features details about aspects of its application in the elimination of malaria.

Rockwell receives SFP patent for GMP formulation

Rockwell Medical a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that it has received notice from the U.S. Patent and Trademark Office for patent issuance on its proprietary GMP formulation for Soluble Ferric Pyrophosphate (SFP), the Company's lead-drug candidate for treating iron deficiency anemia in ESRD patients.

CytRx reports $6.3 million net loss for first quarter 2011

CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the three months ended March 31, 2011, and provided a business update.

Diclofenac in nano-formulated doses provides effective pain relief

A novel formulation of diclofenac provides pain relief at lower-than-standard doses during a Phase II clinical study as reported today at the 2011 World Congress on Osteoarthritis.

Read more Medical News

› Verified 6 days ago